Latest news
Loading news…
Tempus
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Chicago, Illinois, United States Founded 2015 1001-5000 employees For Profit
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Tempus on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalOncologyPrecision Medicine
Total Funding
$2.35B
Funding Rounds
13
Last Funding
Acquisitions
7
Monthly Visits
Contacts
676
Ticker
TEM
NASDAQ
Patents
80
1 trademarks
About Tempus
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- TEM
- Exchange
- NASDAQ
- IPO date
- Jun 14, 2024
- Raised at IPO
- $410.7M
- Valuation at IPO
- $6.1B
- Valuation range
- $1B to $10B
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 37
- Mobile apps
- 4
- Downloads (30d)
- 6
- Active products
- 31
- Patents granted
- 80
- Trademarks
- 1
- IT spend
- $98.12M
Company Info
- Founded
- 2015
- Employees
- 1001-5000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 762
- Events
- 3
- HQ
- Chicago, Illinois, United States
- Region
- Greater Chicago Area, Great Lakes, Midwestern US
- Exit date
- Jun 14, 2024
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.6
- Trend (30d)
- -3.2
- Trend (90d)
- -0.3
- Last leadership hire
- Apr 18, 2025
Tempus Funding Rounds
13 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 13Show
Page 1 / 3
Tempus Acquisitions
9 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Personalis | $1.5B | 2026-07-20 | Tempus | BiotechnologyGeneticsHealth CareHealth Diagnostics | United States |
| Paige | $81.25M | 2025-08-22 | Tempus | Artificial Intelligence (AI)BiopharmaFoundational AIHealth CareHealth DiagnosticsLife ScienceSoftware | United States |
| Deep 6 AI | — | 2025-03-07 | Tempus | AnalyticsArtificial Intelligence (AI)Clinical TrialsHealth CareMachine LearningPharmaceuticalSoftware | United States |
| Ambry Genetics | $600M | 2024-11-06 | Tempus | Health CareHealth DiagnosticsMedical | United States |
| Dawson Forte Cashmere | — | 2024-03-28 | Tempus | FashionRetailTextilesWholesale | United States |
1–5 of 9Show
Page 1 / 2
676
professional contacts at Tempus
Contact execs at Tempus →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Tempus
Loading news…
FAQs about Tempus
People who checked this page also checked these
Sectors Tempus invests & acquires in
Browse the full Acquirezy directory.